Natco Pharma Ltd.
NATCOPHARM Share PricePharmaceuticals & Drugs
₹846.1
-6.6 (-0.8%)
As on September 8, 2025
Exchange Scrips: BSE524816NSENATCOPHARMISININE987B01026
Market Cap ₹ 15,167 Cr
P/E Ratio 8.03
Dividend Yield 0.35 %
Performance
Market performance
Open857.4
High861.3
Volumes3,49,057
Prev846.1
Low844.8
As on2025-09-08
Historical performance
1 Year High1,639
3 Year High1,639
5 Year High1,639
1 Year Low726.8
3 Year Low502
5 Year Low502
Fundamentals
Company Valuation
Market Cap (₹Cr)
15,167
Face Value (₹)
2
P/E Ratio
8.03
Dividend Yield
0.35 %
Investment Returns
1 Year
-45.8%
3 Years
39.4%
5 Years
11.8%
10 Years
94%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 858.41 | Bearish |
| 10-DMA | 861.61 | Bearish |
| 20-DMA | 875.52 | Bearish |
| 50-DMA | 933.62 | Bearish |
| 100-DMA | 898.44 | Bearish |
| 200-DMA | 1,013.27 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 22 | 22 | 21 | 21 | 21 |
| Foreign Investors | 2 | 2 | --- | --- | --- |
| Domestic Investors | 20 | 20 | 21 | 21 | 21 |
| Public Investors | 429412 | 405200 | 345311 | 302923 | 251464 |
| Government | 1 | 1 | --- | --- | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 8.03.
- 3Y Stock Price CAGR of the stock is 12.0.
- The stock has a beta of 0.9.
- In the last financial year, the company had an EBITDA of ₹25505 Million.
- The company generated revenue of ₹44295 Million in the previous financial year.
Natco Pharma Ltd.
846.1-6.6 (-0.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 547194.8
No. of Shares: 647 (Approx)
Performance:-45.3%
P/L: ₹-452805.2
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent